Novare Capital Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,435
Closed -$303K 202
2025
Q1
$303K Sell
3,435
-1,090
-24% -$103K 0.03% 164
2024
Q4
$413K Sell
4,525
-185
-4% -$19K 0.03% 144
2024
Q3
$527K Sell
4,710
-437
-8% -$43.7K 0.04% 136
2024
Q2
$504K Sell
5,147
-1,230
-19% -$122K 0.05% 132
2024
Q1
$639K Sell
6,377
-94,655
-94% -$8.32M 0.06% 123
2023
Q4
$9.07M Buy
101,032
+371
+0.4% +$29.6K 0.92% 48
2023
Q3
$7.72M Buy
100,661
+2,628
+3% +$218K 0.87% 54
2023
Q2
$8.21M Buy
98,033
+550
+0.6% +$44.7K 0.88% 51
2023
Q1
$8.22M Sell
97,483
-4,109
-4% -$353K 0.93% 46
2022
Q4
$8.27M Buy
101,592
+10,529
+12% +$848K 0.98% 43
2022
Q3
$6.47M Buy
91,063
+22,149
+32% +$1.99M 0.83% 53
2022
Q2
$6.19M Buy
68,914
+2,797
+4% +$290K 0.76% 61
2022
Q1
$7.41M Sell
66,117
-104
-0.2% -$12.2K 0.79% 57
2021
Q4
$8.01M Sell
66,221
-772
-1% -$85.8K 0.81% 54
2021
Q3
$6.75M Sell
66,993
-437
-0.6% -$48.2K 0.75% 67
2021
Q2
$7.87M Sell
67,430
-2,062
-3% -$248K 0.88% 53
2021
Q1
$7.65M Sell
69,492
-2,225
-3% -$242K 0.92% 48
2020
Q4
$7.19M Sell
71,717
-3,880
-5% -$360K 0.94% 44
2020
Q3
$5.91M Sell
75,597
-9
-0% -$678 0.83% 56
2020
Q2
$5.26M Buy
75,606
+3,169
+4% +$200K 0.79% 58
2020
Q1
$3.37M Sell
72,437
-1,176
-2% -$75.5K 0.59% 70
2019
Q4
$5.83M Buy
73,613
+3,541
+5% +$272K 0.81% 53
2019
Q3
$5.17M Buy
+70,072
New +$5.03M 0.77% 61

Other funds holding EMN

Novare Capital Management's EMN Position: Q2 2025 in Review

Novare Capital Management sold out of Eastman Chemical (EMN) in Q2 2025, closing a stake of 3,435 shares — an estimated $303K sold.

Novare Capital Management first reported a position in EMN in Q3 2019 and held it in 23 quarters. The position peaked at $9.07M in Q4 2023. 752 funds tracked by Wall St. Rank hold EMN as of Q2 2025.

  • Novare Capital Management reported no remaining Eastman Chemical position as of Q2 2025 after selling out during the quarter.
  • Novare Capital Management sold 3,435 Eastman Chemical shares in Q2 2025, an estimated $303K.
  • Novare Capital Management first reported a position in Eastman Chemical in Q3 2019 and held it in 23 quarters.
  • Novare Capital Management's Eastman Chemical position peaked at $9.07M in Q4 2023.
  • 752 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2025.

Based on Novare Capital Management's 13F filing for Q2 2025, filed 29 Jul 2025.